Home Healthcare Medical Devices Dialyzer Market

Dialyzer Market Size, Share & Trends Analysis Report By Flux Type (High-Flux Dialyzer, Low-Flux Dialyzer), By Usage Type (Disposable, Reusable), By End-User (In-Center Dialysis, Home Dialysis) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: August 24, 2026 | Author: Debashree Bora | Format:

Dialyzer Market Size

The global dialyzer market size was valued at USD 4.99 billion in 2025 and is projected to grow from USD 5.32 billion in 2026 to USD 8.87 billion by 2034, registering a CAGR of 6.6% during the forecast period from 2026 to 2034. North America dominated the dialyzer market with a market share of 37.2% in 2025.

The global dialyzer market is primarily boosted by the surging prevalence of chronic kidney diseases (CKD), which can subsequently lead to end-stage renal disease (ESRD). The patient suffering from this disease increases the demand for dialysis treatment and, subsequently, the dialyzers. Moreover, there has been a surge in the advancement and development of novel dialyzers, enhancing treatment efficiency. This is anticipated to create opportunities for market expansion.

A dialyzer is commonly known as an "artificial kidney." They are alternatively referred to as dialysis machines or hemodialyzers. The primary purpose of this medical procedure is to eliminate surplus waste and fluid from the bloodstream in cases where the patient's kidneys are no longer capable of carrying out this task. Dialyzers consist of a thin, fibrous substance. The fibers create a selectively permeable barrier, allowing tiny particles and liquids to pass.

The dialyzer has four ports, i.e., one inlet and one outlet port for blood and dialysate. The semipermeable dialysis membrane acts as a barrier between the blood and dialysate compartments. The membrane facilitates transport through two mechanisms: diffusion, often known as dialysis, and convection, also known as ultrafiltration. Small solutes are primarily eliminated through diffusion, while bigger components like β2-microglobulin are more efficiently eliminated through convection.

Dialyzer Market Size

Download a Free Sample To learn more about this report.

Flux Type Insights

The global market is segmented into high-flux and low-flux dialyzers. The high-flux dialyzer segment dominates the global market. The high-flux dialyzers had the highest market share and are projected to experience the most rapid growth in the forecast period. High-flux dialyzers' improved efficiency and compatibility effectively eliminate large and medium molecules, such as beta-2 microglobulin, from the blood. These dialyzers enable advanced hemodialysis techniques, such as hemodiafiltration and online hemodialysis.

High-flux dialyzers have membranes with bigger pore sizes, allowing for the efficient elimination of larger molecules that regular dialyzers may not effectively remove. It is crucial for individuals undergoing long-term hemodialysis to be aware that the buildup of specific larger toxins can lead to difficulties as time goes on. Moreover, high-flux dialyzers are the preferred choice for home-based dialysis treatment because they reduce the frequency and duration of dialysis treatments. They also provide improved clinical outcomes and enhance the quality of life for patients.

Dialyzer Market Size By Segments

Request Customizationto receive a tailored report.

Usage Type Insights

The market is bifurcated into disposable and reusable dialyzers. Disposable dialyzers are made with one use in mind: they are meant to be used for a single hemodialysis session and then discarded. Disposable dialyzers provide numerous benefits, including minimizing the risk of infection and preventing cross-contamination among patients. They also eliminate the necessity for extensive sterilizing protocols after each use. Moreover, disposable dialyzers enhance safety and efficiency in the hemodialysis procedure. The Government Kilpauk Medical College (KMC) Hospital implemented a new policy in December 2021, mandating the usage of dialysis equipment for a single patient only. Under the Chief Minister's Comprehensive Health Insurance Scheme (CMCHIS), a new disposable dialyzer and AV tubings would be utilized for each dialysis procedure. These initiatives are expected to stimulate the expansion of the segment.

End-Users Insights

The market is bifurcated into in-center and home dialysis. The in-center dialysis segment owns the highest market share. The increasing demand for in-center dialysis is driven by the presence of skilled medical personnel in hospital-based dialysis centers, leading to improved patient care and expanding the market. Moreover, due to the escalating prevalence of kidney disorders, there is a growing need for dialysis devices at these facilities. Thus, there has been a significant increase in the installation of additional dialysis machines at these facilities. For instance, in October 2020, the Nephrology department at Father Muller Medical College Hospital increased its dialysis capacity by adding three advanced dialysis machines to its existing fleet.

Dialyzer Market Share By Segments

Speak to an Analystto discuss market opportunities.

Regional Insights

North America is the most significant global dialyzer market shareholder and is expected to expand substantially during the forecast period. The regional expansion is propelled by the widespread occurrence of CKD and ESRD, the extensive acceptance of dialysis, prominent dialyzer manufacturers, and the advantageous reimbursement policies for dialysis in the region. Based on a 2023 study from the CDC, it is anticipated that around 35.5 million individuals, or 14% of US adults, have chronic kidney disease (CKD). This disease has a higher prevalence among individuals who are 65 years of age or older, with approximately 34% of the elderly population in the USA affected by it. Similarly, the prevalence of diabetes in the United States is 38.4 million individuals, accounting for 11.6% of the population. Diabetes is the primary factor contributing to renal disorders, leading to an elevated likelihood of developing CKD and ESDR. Therefore, there is an increasing demand for dialyzers.

Furthermore, the market participants are introducing new products in this market to enhance their position. For instance, in December 2020, Medtronic plc introduced the Carpediem™ Cardio-Renal Pediatric Dialysis Emergency Machine to the U.S. market. After receiving commercial authorization from the U.S. Food and Drug Administration (FDA) earlier this year, the first Carpediem™ systems have been installed. They are already being used at Cincinnati Children's Hospital Medical Center. The Carpediem™ system, the first type, is designed for patients with acute renal injury or fluid overload who require hemodialysis or hemofiltration therapy.

  • Similarly, in March 2022, Nipro Medical Corporation (Nipro), a prominent manufacturer and supplier of renal, vascular, and medical-surgical products, introduced the SURDIAL™ DX Hemodialysis System to the U.S. market. The SURDIAL™ DX is an advanced hemodialysis system that aims to provide patients and clinicians with an exceptional dialysis treatment experience. These factors contribute to the growth of the regional market.
North America Dialyzer Market Revenue Share 2025

Unlock Regional Insightsto access country-level data, & regional trends.

Asia Pacific Dialyzer Market Trends

Asia-Pacific is expected to experience significant growth. The region offers substantial growth opportunities due to its substantial patient population, escalating healthcare investments, and increasing awareness regarding renal disorders. Moreover, numerous institutes and organizations in this region are experiencing a significant increase in research and development efforts to create improved and highly efficient devices. For instance, in 2019, a group of Japanese researchers created a compact dialysis device that is the size of a briefcase. This technology is designed to be used by those with renal disease and is intended to be particularly useful in emergencies where medical assistance is limited. As per the researchers, the device is significantly smaller than traditional portable dialysis machines, around the size of a little fridge. It is 30 centimeters in height, 18 centimeters in width, and 12 centimeters in depth. The apparatus weighs between 3 to 4 kilos, including batteries.

Furthermore, the market participants are strategically increasing their presence in this region by offering innovative products to exploit unexplored opportunities. For instance, in September 2019, Fresenius Medical Care, the global dialysis products and services leader, introduced its 4008ATM dialysis machine in China. The device is specifically crafted to integrate Fresenius Medical Care's stringent quality requirements while minimizing expenses for healthcare systems and catering to expanding market demands. Fresenius Medical Care hopes the 4008ATM will enable more Chinese patients with end-stage renal disease (ESRD) to access high-quality, life-sustaining dialysis therapy. All these factors contribute to expanding the regional market.

List of Key and Emerging Players in Dialyzer Market

Asahi Kasei Corporation
B. Braun Melsungen AG
Baxter International Inc.
Cantel Medical Corporation (Steris plc)
Dialife SA
Browndove Healthcare (P) Ltd.
Farmasol
Fresenius Medical Care AG & Co. KGaA
Nipro Corporation
Medica S.p.A.
Medtronic plc
Nikkiso Co. Ltd.
Shandong Weigao Group Medical Polymer Co., Ltd.
Toray Industries Inc.

Key Industry Developments

May 2026
Nikkiso Co., Ltd. expanded its dialysis business by strengthening manufacturing capabilities for dialyzers and related consumables, supporting the growing adoption of home and in-center hemodialysis therapies.
February 2026
Toray Medical expanded production capacity for its polysulfone dialyzer membranes to meet rising global demand for high-performance hemodialysis consumables and strengthen its supply chain.
November 2025
B. Braun expanded its dialysis product portfolio by introducing advanced high-flux dialyzers and bloodline systems for hemodialysis centers, supporting improved treatment performance and patient safety.
September 2025
Fresenius Medical Care expanded the rollout of its FX CorAL high-flux dialyzer in additional international markets, strengthening its dialysis product portfolio with enhanced biocompatibility and improved middle-molecule clearance.

Report Scope

Segmentation

By Flux Type 2
  • High-Flux Dialyzer
  • Low-Flux Dialyzer
By Usage Type 2
  • Disposable
  • Reusable
By End-User 2
  • In-Center Dialysis
  • Home Dialysis

Geographies Covered

North America 2
  • U.S.
  • Canada
Europe 8
  • U.K.
  • Germany
  • France
  • Spain
  • Italy
  • Russia
  • Nordic
  • Benelux
APAC 8
  • China
  • Korea
  • Japan
  • India
  • Australia
  • Singapore
  • Taiwan
  • South East Asia
Middle East and Africa 6
  • UAE
  • Turkey
  • Saudi Arabia
  • South Africa
  • Egypt
  • Nigeria
LATAM 5
  • Brazil
  • Mexico
  • Argentina
  • Chile
  • Colombia
Competitive Coverage Asahi Kasei Corporation · B. Braun Melsungen AG · Baxter International Inc. · Cantel Medical Corporation (Steris plc) · Dialife SA
Research Deliverables Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Customize This Report to Match Your Strategic Objectives

Frequently Asked Questions (FAQs)

The dialyzer market size is valued at USD 5.32 Billion in 2026 and is projected to reach USD 8.87 Billion by 2034, at a CAGR of 6.6% during the forecast period 2026-2034.

North America dominated the market with a share of 37.2% in 2025.

The leading players in this market are Asahi Kasei Corporation, B. Braun Melsungen AG, Baxter International Inc., Cantel Medical Corporation, Dialife SA.

The dialyzer market is projected to grow at a CAGR of 6.6% during the forecast period of 2026 2034.
About the Author
Debashree Bora
Debashree Bora
Healthcare Lead

Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, and competitive dynamics.
Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.

Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Request Sample Order Report Now

We are featured on: